申请人:Janssen Pharmaceutica NV
公开号:US20170158673A1
公开(公告)日:2017-06-08
The present invention provides compounds of formula (I), their use as PARP inhibitors as well as pharmaceutical compositions comprising said compounds of formula (I)
wherein R
1
, R
2
, R
3
, L, X, Y and Z have defined meanings.